Global Neoantigen Targeted Therapies Market Growth (Status and Outlook) 2024-2030

March 2024 | 88 pages | ID: G8B6D9A10C63EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Neoantigen Targeted Therapies market size was valued at US$ million in 2023. With growing demand in downstream market, the Neoantigen Targeted Therapies is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.

The research report highlights the growth potential of the global Neoantigen Targeted Therapies market. Neoantigen Targeted Therapies are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Neoantigen Targeted Therapies. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Neoantigen Targeted Therapies market.

Recent developments in genomic analysis and advances in bioinformatics have enabled the adoption of more personalized treatment approaches, such as neoantigen targeted therapies. Cancer neoantigens is a term used to refer to a subset of antigens encoded by tumor-specific, mutated genes, which have not previously been recognized by the host’s immune system.

Key Features:

The report on Neoantigen Targeted Therapies market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Neoantigen Targeted Therapies market. It may include historical data, market segmentation by Type (e.g., Monotherapy, Combination Therapy), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Neoantigen Targeted Therapies market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Neoantigen Targeted Therapies market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Neoantigen Targeted Therapies industry. This include advancements in Neoantigen Targeted Therapies technology, Neoantigen Targeted Therapies new entrants, Neoantigen Targeted Therapies new investment, and other innovations that are shaping the future of Neoantigen Targeted Therapies.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Neoantigen Targeted Therapies market. It includes factors influencing customer ' purchasing decisions, preferences for Neoantigen Targeted Therapies product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Neoantigen Targeted Therapies market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Neoantigen Targeted Therapies market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Neoantigen Targeted Therapies market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Neoantigen Targeted Therapies industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Neoantigen Targeted Therapies market.

Market Segmentation:

Neoantigen Targeted Therapies market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type

• Monotherapy
• Combination Therapy

Segmentation by application

• Medical Research Institution
• Hospital and Clinic
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Bavarian Nordic
• Genocea Biosciences
• Gradalis
• Immunicum
• Immunovative Therapies
• Iovance Biotherapeutics
• MediGene
• Neon Therapeutics

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Neoantigen Targeted Therapies Market Size 2019-2030
  2.1.2 Neoantigen Targeted Therapies Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Neoantigen Targeted Therapies Segment by Type
  2.2.1 Monotherapy
  2.2.2 Combination Therapy
2.3 Neoantigen Targeted Therapies Market Size by Type
  2.3.1 Neoantigen Targeted Therapies Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Neoantigen Targeted Therapies Market Size Market Share by Type (2019-2024)
2.4 Neoantigen Targeted Therapies Segment by Application
  2.4.1 Medical Research Institution
  2.4.2 Hospital and Clinic
  2.4.3 Other
2.5 Neoantigen Targeted Therapies Market Size by Application
  2.5.1 Neoantigen Targeted Therapies Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Neoantigen Targeted Therapies Market Size Market Share by Application (2019-2024)

3 NEOANTIGEN TARGETED THERAPIES MARKET SIZE BY PLAYER

3.1 Neoantigen Targeted Therapies Market Size Market Share by Players
  3.1.1 Global Neoantigen Targeted Therapies Revenue by Players (2019-2024)
  3.1.2 Global Neoantigen Targeted Therapies Revenue Market Share by Players (2019-2024)
3.2 Global Neoantigen Targeted Therapies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 NEOANTIGEN TARGETED THERAPIES BY REGIONS

4.1 Neoantigen Targeted Therapies Market Size by Regions (2019-2024)
4.2 Americas Neoantigen Targeted Therapies Market Size Growth (2019-2024)
4.3 APAC Neoantigen Targeted Therapies Market Size Growth (2019-2024)
4.4 Europe Neoantigen Targeted Therapies Market Size Growth (2019-2024)
4.5 Middle East & Africa Neoantigen Targeted Therapies Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Neoantigen Targeted Therapies Market Size by Country (2019-2024)
5.2 Americas Neoantigen Targeted Therapies Market Size by Type (2019-2024)
5.3 Americas Neoantigen Targeted Therapies Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Neoantigen Targeted Therapies Market Size by Region (2019-2024)
6.2 APAC Neoantigen Targeted Therapies Market Size by Type (2019-2024)
6.3 APAC Neoantigen Targeted Therapies Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Neoantigen Targeted Therapies by Country (2019-2024)
7.2 Europe Neoantigen Targeted Therapies Market Size by Type (2019-2024)
7.3 Europe Neoantigen Targeted Therapies Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Neoantigen Targeted Therapies by Region (2019-2024)
8.2 Middle East & Africa Neoantigen Targeted Therapies Market Size by Type (2019-2024)
8.3 Middle East & Africa Neoantigen Targeted Therapies Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL NEOANTIGEN TARGETED THERAPIES MARKET FORECAST

10.1 Global Neoantigen Targeted Therapies Forecast by Regions (2025-2030)
  10.1.1 Global Neoantigen Targeted Therapies Forecast by Regions (2025-2030)
  10.1.2 Americas Neoantigen Targeted Therapies Forecast
  10.1.3 APAC Neoantigen Targeted Therapies Forecast
  10.1.4 Europe Neoantigen Targeted Therapies Forecast
  10.1.5 Middle East & Africa Neoantigen Targeted Therapies Forecast
10.2 Americas Neoantigen Targeted Therapies Forecast by Country (2025-2030)
  10.2.1 United States Neoantigen Targeted Therapies Market Forecast
  10.2.2 Canada Neoantigen Targeted Therapies Market Forecast
  10.2.3 Mexico Neoantigen Targeted Therapies Market Forecast
  10.2.4 Brazil Neoantigen Targeted Therapies Market Forecast
10.3 APAC Neoantigen Targeted Therapies Forecast by Region (2025-2030)
  10.3.1 China Neoantigen Targeted Therapies Market Forecast
  10.3.2 Japan Neoantigen Targeted Therapies Market Forecast
  10.3.3 Korea Neoantigen Targeted Therapies Market Forecast
  10.3.4 Southeast Asia Neoantigen Targeted Therapies Market Forecast
  10.3.5 India Neoantigen Targeted Therapies Market Forecast
  10.3.6 Australia Neoantigen Targeted Therapies Market Forecast
10.4 Europe Neoantigen Targeted Therapies Forecast by Country (2025-2030)
  10.4.1 Germany Neoantigen Targeted Therapies Market Forecast
  10.4.2 France Neoantigen Targeted Therapies Market Forecast
  10.4.3 UK Neoantigen Targeted Therapies Market Forecast
  10.4.4 Italy Neoantigen Targeted Therapies Market Forecast
  10.4.5 Russia Neoantigen Targeted Therapies Market Forecast
10.5 Middle East & Africa Neoantigen Targeted Therapies Forecast by Region (2025-2030)
  10.5.1 Egypt Neoantigen Targeted Therapies Market Forecast
  10.5.2 South Africa Neoantigen Targeted Therapies Market Forecast
  10.5.3 Israel Neoantigen Targeted Therapies Market Forecast
  10.5.4 Turkey Neoantigen Targeted Therapies Market Forecast
  10.5.5 GCC Countries Neoantigen Targeted Therapies Market Forecast
10.6 Global Neoantigen Targeted Therapies Forecast by Type (2025-2030)
10.7 Global Neoantigen Targeted Therapies Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Bavarian Nordic
  11.1.1 Bavarian Nordic Company Information
  11.1.2 Bavarian Nordic Neoantigen Targeted Therapies Product Offered
  11.1.3 Bavarian Nordic Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Bavarian Nordic Main Business Overview
  11.1.5 Bavarian Nordic Latest Developments
11.2 Genocea Biosciences
  11.2.1 Genocea Biosciences Company Information
  11.2.2 Genocea Biosciences Neoantigen Targeted Therapies Product Offered
  11.2.3 Genocea Biosciences Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Genocea Biosciences Main Business Overview
  11.2.5 Genocea Biosciences Latest Developments
11.3 Gradalis
  11.3.1 Gradalis Company Information
  11.3.2 Gradalis Neoantigen Targeted Therapies Product Offered
  11.3.3 Gradalis Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Gradalis Main Business Overview
  11.3.5 Gradalis Latest Developments
11.4 Immunicum
  11.4.1 Immunicum Company Information
  11.4.2 Immunicum Neoantigen Targeted Therapies Product Offered
  11.4.3 Immunicum Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Immunicum Main Business Overview
  11.4.5 Immunicum Latest Developments
11.5 Immunovative Therapies
  11.5.1 Immunovative Therapies Company Information
  11.5.2 Immunovative Therapies Neoantigen Targeted Therapies Product Offered
  11.5.3 Immunovative Therapies Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Immunovative Therapies Main Business Overview
  11.5.5 Immunovative Therapies Latest Developments
11.6 Iovance Biotherapeutics
  11.6.1 Iovance Biotherapeutics Company Information
  11.6.2 Iovance Biotherapeutics Neoantigen Targeted Therapies Product Offered
  11.6.3 Iovance Biotherapeutics Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Iovance Biotherapeutics Main Business Overview
  11.6.5 Iovance Biotherapeutics Latest Developments
11.7 MediGene
  11.7.1 MediGene Company Information
  11.7.2 MediGene Neoantigen Targeted Therapies Product Offered
  11.7.3 MediGene Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 MediGene Main Business Overview
  11.7.5 MediGene Latest Developments
11.8 Neon Therapeutics
  11.8.1 Neon Therapeutics Company Information
  11.8.2 Neon Therapeutics Neoantigen Targeted Therapies Product Offered
  11.8.3 Neon Therapeutics Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Neon Therapeutics Main Business Overview
  11.8.5 Neon Therapeutics Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Neoantigen Targeted Therapies Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Monotherapy
Table 3. Major Players of Combination Therapy
Table 4. Neoantigen Targeted Therapies Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Neoantigen Targeted Therapies Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Neoantigen Targeted Therapies Market Size Market Share by Type (2019-2024)
Table 7. Neoantigen Targeted Therapies Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Neoantigen Targeted Therapies Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Neoantigen Targeted Therapies Market Size Market Share by Application (2019-2024)
Table 10. Global Neoantigen Targeted Therapies Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Neoantigen Targeted Therapies Revenue Market Share by Player (2019-2024)
Table 12. Neoantigen Targeted Therapies Key Players Head office and Products Offered
Table 13. Neoantigen Targeted Therapies Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Neoantigen Targeted Therapies Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Neoantigen Targeted Therapies Market Size Market Share by Regions (2019-2024)
Table 18. Global Neoantigen Targeted Therapies Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Neoantigen Targeted Therapies Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Neoantigen Targeted Therapies Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Neoantigen Targeted Therapies Market Size Market Share by Country (2019-2024)
Table 22. Americas Neoantigen Targeted Therapies Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Neoantigen Targeted Therapies Market Size Market Share by Type (2019-2024)
Table 24. Americas Neoantigen Targeted Therapies Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Neoantigen Targeted Therapies Market Size Market Share by Application (2019-2024)
Table 26. APAC Neoantigen Targeted Therapies Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Neoantigen Targeted Therapies Market Size Market Share by Region (2019-2024)
Table 28. APAC Neoantigen Targeted Therapies Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Neoantigen Targeted Therapies Market Size Market Share by Type (2019-2024)
Table 30. APAC Neoantigen Targeted Therapies Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Neoantigen Targeted Therapies Market Size Market Share by Application (2019-2024)
Table 32. Europe Neoantigen Targeted Therapies Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Neoantigen Targeted Therapies Market Size Market Share by Country (2019-2024)
Table 34. Europe Neoantigen Targeted Therapies Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Neoantigen Targeted Therapies Market Size Market Share by Type (2019-2024)
Table 36. Europe Neoantigen Targeted Therapies Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Neoantigen Targeted Therapies Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Neoantigen Targeted Therapies Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Neoantigen Targeted Therapies Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Neoantigen Targeted Therapies Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Neoantigen Targeted Therapies Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Neoantigen Targeted Therapies Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Neoantigen Targeted Therapies Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Neoantigen Targeted Therapies
Table 45. Key Market Challenges & Risks of Neoantigen Targeted Therapies
Table 46. Key Industry Trends of Neoantigen Targeted Therapies
Table 47. Global Neoantigen Targeted Therapies Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Neoantigen Targeted Therapies Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Neoantigen Targeted Therapies Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Neoantigen Targeted Therapies Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Bavarian Nordic Details, Company Type, Neoantigen Targeted Therapies Area Served and Its Competitors
Table 52. Bavarian Nordic Neoantigen Targeted Therapies Product Offered
Table 53. Bavarian Nordic Neoantigen Targeted Therapies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Bavarian Nordic Main Business
Table 55. Bavarian Nordic Latest Developments
Table 56. Genocea Biosciences Details, Company Type, Neoantigen Targeted Therapies Area Served and Its Competitors
Table 57. Genocea Biosciences Neoantigen Targeted Therapies Product Offered
Table 58. Genocea Biosciences Main Business
Table 59. Genocea Biosciences Neoantigen Targeted Therapies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Genocea Biosciences Latest Developments
Table 61. Gradalis Details, Company Type, Neoantigen Targeted Therapies Area Served and Its Competitors
Table 62. Gradalis Neoantigen Targeted Therapies Product Offered
Table 63. Gradalis Main Business
Table 64. Gradalis Neoantigen Targeted Therapies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Gradalis Latest Developments
Table 66. Immunicum Details, Company Type, Neoantigen Targeted Therapies Area Served and Its Competitors
Table 67. Immunicum Neoantigen Targeted Therapies Product Offered
Table 68. Immunicum Main Business
Table 69. Immunicum Neoantigen Targeted Therapies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Immunicum Latest Developments
Table 71. Immunovative Therapies Details, Company Type, Neoantigen Targeted Therapies Area Served and Its Competitors
Table 72. Immunovative Therapies Neoantigen Targeted Therapies Product Offered
Table 73. Immunovative Therapies Main Business
Table 74. Immunovative Therapies Neoantigen Targeted Therapies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Immunovative Therapies Latest Developments
Table 76. Iovance Biotherapeutics Details, Company Type, Neoantigen Targeted Therapies Area Served and Its Competitors
Table 77. Iovance Biotherapeutics Neoantigen Targeted Therapies Product Offered
Table 78. Iovance Biotherapeutics Main Business
Table 79. Iovance Biotherapeutics Neoantigen Targeted Therapies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Iovance Biotherapeutics Latest Developments
Table 81. MediGene Details, Company Type, Neoantigen Targeted Therapies Area Served and Its Competitors
Table 82. MediGene Neoantigen Targeted Therapies Product Offered
Table 83. MediGene Main Business
Table 84. MediGene Neoantigen Targeted Therapies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. MediGene Latest Developments
Table 86. Neon Therapeutics Details, Company Type, Neoantigen Targeted Therapies Area Served and Its Competitors
Table 87. Neon Therapeutics Neoantigen Targeted Therapies Product Offered
Table 88. Neon Therapeutics Main Business
Table 89. Neon Therapeutics Neoantigen Targeted Therapies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Neon Therapeutics Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Neoantigen Targeted Therapies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neoantigen Targeted Therapies Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Neoantigen Targeted Therapies Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Neoantigen Targeted Therapies Sales Market Share by Country/Region (2023)
Figure 8. Neoantigen Targeted Therapies Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Neoantigen Targeted Therapies Market Size Market Share by Type in 2023
Figure 10. Neoantigen Targeted Therapies in Medical Research Institution
Figure 11. Global Neoantigen Targeted Therapies Market: Medical Research Institution (2019-2024) & ($ Millions)
Figure 12. Neoantigen Targeted Therapies in Hospital and Clinic
Figure 13. Global Neoantigen Targeted Therapies Market: Hospital and Clinic (2019-2024) & ($ Millions)
Figure 14. Neoantigen Targeted Therapies in Other
Figure 15. Global Neoantigen Targeted Therapies Market: Other (2019-2024) & ($ Millions)
Figure 16. Global Neoantigen Targeted Therapies Market Size Market Share by Application in 2023
Figure 17. Global Neoantigen Targeted Therapies Revenue Market Share by Player in 2023
Figure 18. Global Neoantigen Targeted Therapies Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Neoantigen Targeted Therapies Market Size 2019-2024 ($ Millions)
Figure 20. APAC Neoantigen Targeted Therapies Market Size 2019-2024 ($ Millions)
Figure 21. Europe Neoantigen Targeted Therapies Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Neoantigen Targeted Therapies Market Size 2019-2024 ($ Millions)
Figure 23. Americas Neoantigen Targeted Therapies Value Market Share by Country in 2023
Figure 24. United States Neoantigen Targeted Therapies Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Neoantigen Targeted Therapies Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Neoantigen Targeted Therapies Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Neoantigen Targeted Therapies Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Neoantigen Targeted Therapies Market Size Market Share by Region in 2023
Figure 29. APAC Neoantigen Targeted Therapies Market Size Market Share by Type in 2023
Figure 30. APAC Neoantigen Targeted Therapies Market Size Market Share by Application in 2023
Figure 31. China Neoantigen Targeted Therapies Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Neoantigen Targeted Therapies Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Neoantigen Targeted Therapies Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Neoantigen Targeted Therapies Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Neoantigen Targeted Therapies Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Neoantigen Targeted Therapies Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Neoantigen Targeted Therapies Market Size Market Share by Country in 2023
Figure 38. Europe Neoantigen Targeted Therapies Market Size Market Share by Type (2019-2024)
Figure 39. Europe Neoantigen Targeted Therapies Market Size Market Share by Application (2019-2024)
Figure 40. Germany Neoantigen Targeted Therapies Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Neoantigen Targeted Therapies Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Neoantigen Targeted Therapies Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Neoantigen Targeted Therapies Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Neoantigen Targeted Therapies Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Neoantigen Targeted Therapies Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Neoantigen Targeted Therapies Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Neoantigen Targeted Therapies Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Neoantigen Targeted Therapies Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Neoantigen Targeted Therapies Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Neoantigen Targeted Therapies Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Neoantigen Targeted Therapies Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Neoantigen Targeted Therapies Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Neoantigen Targeted Therapies Market Size 2025-2030 ($ Millions)
Figure 54. APAC Neoantigen Targeted Therapies Market Size 2025-2030 ($ Millions)
Figure 55. Europe Neoantigen Targeted Therapies Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Neoantigen Targeted Therapies Market Size 2025-2030 ($ Millions)
Figure 57. United States Neoantigen Targeted Therapies Market Size 2025-2030 ($ Millions)
Figure 58. Canada Neoantigen Targeted Therapies Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Neoantigen Targeted Therapies Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Neoantigen Targeted Therapies Market Size 2025-2030 ($ Millions)
Figure 61. China Neoantigen Targeted Therapies Market Size 2025-2030 ($ Millions)
Figure 62. Japan Neoantigen Targeted Therapies Market Size 2025-2030 ($ Millions)
Figure 63. Korea Neoantigen Targeted Therapies Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Neoantigen Targeted Therapies Market Size 2025-2030 ($ Millions)
Figure 65. India Neoantigen Targeted Therapies Market Size 2025-2030 ($ Millions)
Figure 66. Australia Neoantigen Targeted Therapies Market Size 2025-2030 ($ Millions)
Figure 67. Germany Neoantigen Targeted Therapies Market Size 2025-2030 ($ Millions)
Figure 68. France Neoantigen Targeted Therapies Market Size 2025-2030 ($ Millions)
Figure 69. UK Neoantigen Targeted Therapies Market Size 2025-2030 ($ Millions)
Figure 70. Italy Neoantigen Targeted Therapies Market Size 2025-2030 ($ Millions)
Figure 71. Russia Neoantigen Targeted Therapies Market Size 2025-2030 ($ Millions)
Figure 72. Spain Neoantigen Targeted Therapies Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Neoantigen Targeted Therapies Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Neoantigen Targeted Therapies Market Size 2025-2030 ($ Millions)
Figure 75. Israel Neoantigen Targeted Therapies Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Neoantigen Targeted Therapies Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Neoantigen Targeted Therapies Market Size 2025-2030 ($ Millions)
Figure 78. Global Neoantigen Targeted Therapies Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Neoantigen Targeted Therapies Market Size Market Share Forecast by Application (2025-2030)